These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19118222)

  • 1. Safety of long-acting beta-agonists: urgent need to clear the air remains.
    Beasley R; Martinez FD; Hackshaw A; Rabe KF; Sterk PJ; Djukanovic R
    Eur Respir J; 2009 Jan; 33(1):3-5. PubMed ID: 19118222
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of long-acting beta-agonists--an urgent need to clear the air.
    Martinez FD
    N Engl J Med; 2005 Dec; 353(25):2637-9. PubMed ID: 16371628
    [No Abstract]   [Full Text] [Related]  

  • 3. The controversy over long-acting beta agonists: examining the evidence.
    Lang DM
    Cleve Clin J Med; 2006 Nov; 73(11):973-6, 978, 981-4 passim. PubMed ID: 17128539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summaries for patients. What are the risks of using inhaled long-acting beta-agonist medications for the relief of asthma?
    Ann Intern Med; 2006 Jun; 144(12):I30. PubMed ID: 16785474
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenetics of beta(2)-agonists in children.
    Kabesch M
    J Allergy Clin Immunol; 2009 Dec; 124(6):1195-6. PubMed ID: 19910024
    [No Abstract]   [Full Text] [Related]  

  • 6. Are there any detrimental effects of the use of inhaled long-acting beta 2-agonists in the treatment of asthma?
    Devoy MA; Fuller RW; Palmer JB
    Chest; 1995 Apr; 107(4):1116-24. PubMed ID: 7705125
    [No Abstract]   [Full Text] [Related]  

  • 7. Asthma exacerbations and formoterol.
    Rissmiller RW; Larj MJ; Peters SP; Bleecker ER
    Chest; 2004 Apr; 125(4):1590-1. PubMed ID: 15078782
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-acting beta(2)-adrenoceptor agonists for asthma and COPD].
    Rabe KF; Ukena D; Magnussen H
    Med Klin (Munich); 1997 Dec; 92 Suppl 5():44-9. PubMed ID: 19479397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salmeterol and formoterol: asthma aggravation. Use should be restricted.
    Prescrire Int; 2009 Aug; 18(102):166. PubMed ID: 19743580
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths.
    Salpeter SR; Buckley NS; Ormiston TM; Salpeter EE
    Ann Intern Med; 2006 Jun; 144(12):904-12. PubMed ID: 16754916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term studies on long-acting sympathomimetics.
    Larsson S
    Lung; 1990; 168 Suppl():22-4. PubMed ID: 1974680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIASMA: asthma exacerbation reduction with salmeterol.
    Shrewsbury S; Pyke S
    Chest; 2002 Mar; 121(3):1002-4. PubMed ID: 11888994
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA panel: ban 2 popular asthma drugs.
    Kuehn BM
    JAMA; 2009 Jan; 301(4):365-6. PubMed ID: 19176431
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open-label trial.
    Condemi JJ
    Clin Ther; 2001 Sep; 23(9):1529-41. PubMed ID: 11589265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting beta(2)-agonists in childhood asthma: Don't change a winning team (yet).
    Verberne AA; de Jongste JC
    Pediatr Pulmonol; 2000 Mar; 29(3):169-71. PubMed ID: 10686035
    [No Abstract]   [Full Text] [Related]  

  • 17. Basic pharmacology of new long-acting sympathomimetics.
    Löfdahl CG
    Lung; 1990; 168 Suppl():18-21. PubMed ID: 1974674
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia.
    Cazzola M; Imperatore F; Salzillo A; Di Perna F; Calderaro F; Imperatore A; Matera MG
    Chest; 1998 Aug; 114(2):411-5. PubMed ID: 9726723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature.
    Bisgaard H
    Pediatr Pulmonol; 2000 Mar; 29(3):221-34. PubMed ID: 10686044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.